original ) (raw )Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine
George Therapondos , Seham Noureldin
Applied Physiology Nutrition and Metabolism, 2013
View PDFchevron_right
Circulating Phospholipid Patterns in NAFLD Patients Associated with a Combination of Metabolic Risk Factors
Walee Chamulitrat
Nutrients, 2018
View PDFchevron_right
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
Elisabetta Bugianesi
Hepatology, 2010
View PDFchevron_right
Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene
Fausto Machicao , Konstantinos Kantartzis
Diabetes, 2009
View PDFchevron_right
Detection of patatin-like phospholipase domain-containing protein 3 in nonalcoholic fatty liver disease among egyptian patients
Ossama Ahmed
The Egyptian Journal of Internal Medicine, 2019
View PDFchevron_right
Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants
pasquale pignatelli
European journal of internal medicine, 2014
View PDFchevron_right
Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease
ashwani kapoor
Cell Metabolism, 2012
View PDFchevron_right
Relationship between non-alcoholic fatty liver disease and kidney function: A communication between two organs that needs further exploration
Shareef Syed
Arab Journal of Gastroenterology, 2012
View PDFchevron_right
Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: results from the WELCOME trial
Annette West
Journal of hepatology, 2015
View PDFchevron_right
Molecular pathways in non-alcoholic fatty liver disease
Esther Guiu-Jurado , Alba Berlanga , Teresa Auguet
Clinical and Experimental Gastroenterology, 2014
View PDFchevron_right
Non-Alcoholic Fatty Liver Disease: Pathogenesis and the Significance of High-Density Lipoprotein as a Molecular Modifier
IBRAHIM KWAIFA
IntechOpen eBooks, 2023
View PDFchevron_right
Lysophospholipid Metabolism and Signalling in Non-Alcoholic Fatty Liver Disease
IOANNIS TENTES
Folia Medica, 2022
View PDFchevron_right
Altered Fatty Acid Metabolism-Related Gene Expression in Liver from Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
Esther Guiu-Jurado , Gemma Aragonès , Alba Berlanga , Teresa Auguet
International Journal of Molecular Sciences, 2014
View PDFchevron_right
Cholesterol and nonalcoholic fatty liver disease: Renewed focus on an old villain
Nicholas Davidson
Hepatology, 2012
View PDFchevron_right
Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver
Rainer Lehmann
2013
View PDFchevron_right
Genetic Factors Involved in the Development and Progression of Nonalcoholic Fatty Liver Disease
David Neagoe
Current Health Sciences Journal, 2015
View PDFchevron_right
The genes that underlie fatty liver disease: The harvest has begun
Ralf Weiskirchen
Hepatology, 2009
View PDFchevron_right
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
Luca Valenti
BioMed Research International, 2015
View PDFchevron_right
The Association of Nicotinamide Phosphoribosyltransferase Polymorphism with Markers of Hepatic Injury and De Novo Lipogenesis in Nonalcoholic Fatty Liver Disease
Parvaneh Rahimi-Moghaddam
Hepatitis Monthly
View PDFchevron_right
Lipid phenotypes in patients with nonalcoholic fatty liver disease
Tingting Du
Metabolism, 2016
View PDFchevron_right
Diagnosing Fatty Liver Disease: A Comparative Evaluation of Metabolic Markers, Phenotypes, Genotypes and Established Biomarkers
Michael Nothnagel
PLoS ONE, 2013
View PDFchevron_right
A lipidomic analysis of nonalcoholic fatty liver disease
Rebecca Baillie
Hepatology, 2007
View PDFchevron_right
Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease
Onder Sahin
Metabolic Syndrome and Related Disorders, 2012
View PDFchevron_right
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease
Luca Miele
Hepatology communications, 2018
View PDFchevron_right
Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease
Aila Rissanen
Journal of Gastroenterology and Hepatology, 2012
View PDFchevron_right
PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: The NHLBI Family Heart Study
Mariaelisa Graff
View PDFchevron_right
Association of metabolic syndrome and patatin‐like phospholipase 3 – rs738409 gene variant in non‐alcoholic fatty liver disease among a Chennai‐based south Indian population
Arunkumar Ramachandran
The Journal of Gene Medicine, 2020
View PDFchevron_right
Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
Jafor Sadeque
Cureus, 2021
View PDFchevron_right
Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease
Shira Zelber-sagi , Muriel Webb , Zamir Halpern
Liver International, 2013
View PDFchevron_right
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
Jean-francois Dufour , Sven Francque , Guruprasad P Aithal
Nature Communications, 2014
View PDFchevron_right